Single dose of HPV vaccine cuts cervical disease
Study adds to emerging evidence that one dose is effective in HPV-naive cohorts, says Aussie researcher
11th February 2020
Even a single dose of HPV vaccine in young women is associated with a reduced incidence of preinvasive cervical disease, a study shows.
Receiving one, two or three doses of HPV vaccine in girls aged 15-19 is associated with a reduced incidence of preinvasive cancer, according to research using US health insurance data.
Numerous studies of the protectiveness of various numbers of doses of HPV vaccine have yielded mixed results. For females starting vaccination after age 15, three doses are still recommended at zero, 1-2